Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy and serum potassium.

G J McCleane, J P Howe

    The Ulster Medical Journal
    |October 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Electroconvulsive therapy (ECT) with methohexitone and suxamethonium causes a significant but not clinically important rise in serum potassium. The duration of the ECT-induced seizure does not affect this potassium increase.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo controlled trial (Pain 2002; 99: 557-66).

    Pain·2003
    Same author

    The addition of glyceryltrinitrate to capsaicin cream reduces the thermal allodynia associated with the application of capsaicin alone in humans.

    Neuroscience letters·2002
    Same author

    Lamotrigine in the management of neuropathic pain: a review of the literature.

    The Clinical journal of pain·2001
    Same author

    The cholecystokinin antagonist proglumide has an analgesic effect in chronic pancreatitis.

    Pancreas·2000
    Same author

    Medical oxygen and air travel.

    Aviation, space, and environmental medicine·2000
    Same author

    Inflight medical emergencies.

    Aviation, space, and environmental medicine·2000
    Same journal

    Curiositas - Medicine in the Kitchen.

    The Ulster medical journal·2026
    Same journal

    Royal Victoria Hospital Annual Oration, 3rd October 2025.

    The Ulster medical journal·2026
    Same journal

    Thrombosis and Survival after Prothrombin Complex Concentrate Use to treat Oral Anticoagulant Associated Haemorrhage.

    The Ulster medical journal·2026
    Same journal

    Investigating Iron Deficiency Anaemia in the Elderly.

    The Ulster medical journal·2026
    Same journal

    Avoiding Prescribing Pitfalls to Tackle Problematic Polypharmacy and Adverse Drug Reactions in Northern Ireland.

    The Ulster medical journal·2026
    Same journal

    Sir Benjamin William Rycroft: Reflections on Character and Career.

    The Ulster medical journal·2026
    See all related articles

    Area of Science:

    • Anesthesiology
    • Neuroscience
    • Clinical Chemistry

    Background:

    • Electroconvulsive therapy (ECT) is a medical treatment most often used for patients with severe major depression or bipolar disorder that has not responded to other treatments.
    • Anesthetic agents like methohexitone and muscle relaxants such as suxamethonium are commonly used during ECT procedures.
    • Changes in serum potassium levels can have implications for cardiac function, particularly during procedures involving physiological stress like ECT.

    Purpose of the Study:

    • To investigate the effect of electroconvulsive therapy (ECT), when administered with methohexitone and suxamethonium, on serum potassium concentrations.
    • To determine if the duration of the induced convulsion influences the change in serum potassium levels.
    • To assess the clinical significance of observed serum potassium changes in patients undergoing ECT.

    Related Experiment Videos

    Main Methods:

    • Serum potassium levels were measured in 54 patients before and after ECT, which was modified by methohexitone and suxamethonium.
    • A subset of 11 patients received methohexitone alone without ECT to isolate the anesthetic's effect.
    • Statistical analysis was performed to evaluate the significance of changes in serum potassium and the impact of convulsion duration.

    Main Results:

    • A statistically significant increase in serum potassium was observed following ECT with methohexitone and suxamethonium.
    • The duration of the induced convulsion did not significantly affect the magnitude of the serum potassium rise.
    • In patients receiving methohexitone alone, serum potassium levels decreased, indicating a contrasting effect to the ECT combination.

    Conclusions:

    • The combination of methohexitone, suxamethonium, and ECT induces a rise in serum potassium that is generally not clinically significant.
    • This potassium elevation is unlikely to pose a risk unless the pre-induction serum potassium level is already abnormally high.
    • Prolonged seizure duration during ECT does not exacerbate the observed increase in serum potassium.